Newfeed

OSLO, Norway, March 18, 2024 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today the Phase III clinical study results for its non-surgical treatment candidate for cervical high-grade squamo

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: